Preclinical Safety Evaluation of Engineered Lactococcus lactis NZ3900 Biotherapeutics Using a 13-Week Repeated Dose Oral Toxicity Study in Rabbits

References

• Azizpour, M., S. D. Hosseini, P. Jafari, and N. Akbary. 2017. Lactococcus lactis: A new strategy for vaccination. Avicenna. J. Med. Biotechnol. 9 (4):163–168.
   PubMedGoogle Scholar
• Buckley, L. F., and A. Abbate. 2018. Interleukin-1 blockade in cardiovascular diseases: A clinical update. Eur. Heart J. 39 (22):2063–2069. doi:10.1093/eurheartj/ehy128.
   PubMed Web of Science ®Google Scholar
• Charbonneau, M. R., V. M. Isabella, N. Li, and C. B. Kurtz. 2020. Developing a new class of engineered live bacterial therapeutics to treat human diseases. Nat. Commun. 11 (1):1738. doi:10.1038/s41467-020-15508-1.
   PubMed Web of Science ®Google Scholar
• Daniel, C., Y. Roussel, M. Kleerebezem, and B. Pot. 2011. Recombinant lactic acid bacteria as mucosal biotherapeutic agents. Trends Biotechnol. 29 (10):499–508. doi:10.1016/j.tibtech.2011.05.002.
   PubMed Web of Science ®Google Scholar
• de Lacerda, J. R. M., T. F. da Silva, R. E. Vollu, J. M. Marques, and L. Seldin. 2016. Generally recognized as safe (GRAS) Lactococcus lactis strains associated with Lippia sidoides Cham. are able to solubilize/mineralize phosphate. SpringerPlus 5 (1):828. doi:10.1186/s40064-016-2596-4.
   PubMedGoogle Scholar
• de Ruyter, P. G., O. P. Kuipers, M. M. Beerthuyzen, I. van Alen-Boerrigter, and W. M. de Vos. 1996. Functional analysis of promoters in the nisin gene cluster of Lactococcus lactis. J. Bacteriol. 178 (12):3434–3439. doi:10.1128/jb.178.12.3434-3439.1996.
   PubMed Web of Science ®Google Scholar
• Emmi, G., M. L. Urban, M. Imazio, M. Gattorno, S. Maestroni, G. Lopalco, L. Cantarini, D. Prisco, and A. Brucato. 2018. Use of interleukin-1 blockers in pericardial and cardiovascular diseases. Curr.Cardiol. Rep. 20 (8):61. doi:10.1007/s11886-018-1007-6.
   PubMed Web of Science ®Google Scholar
• Freidl, R., A. Gstoettner, U. Baranyi, I. Swoboda, F. Stolz, M. Focke-Tejkl, T. Wekerle, R. van Ree, R. Valenta, and B. Linhart. 2017. Blocking antibodies induced by immunization with a hypoallergenic parvalbumin mutant reduce allergic symptoms in a mouse model of fish allergy. J. Allergy Clin. Immunol. 139 (6):1897–1905. doi:10.1016/j.jaci.2016.10.018.
   PubMed Web of Science ®Google Scholar
• Hugenholtz, J., and E. J. Smid. 2002. Nutraceutical production with food-grade microorganisms. Curr. Opin. Biotechnol. 13 (5):497–507. doi:10.1016/S0958-1669(02)00367-1.
   PubMed Web of Science ®Google Scholar
• Kataria, Y., C. Ellervik, and T. Mandrup-Poulsen. 2019. Treatment of type 2 diabetes by targeting interleukin-1: A meta-analysis of 2921 patients. Semin. Immunopathol. 41 (4):413–425. doi:10.1007/s00281-019-00743-6.
   PubMed Web of Science ®Google Scholar
• Kawana, K., K. Adachi, S. Kojima, A. Taguchi, K. Tomio, A. Yamashita, H. Nishida, K. Nagasaka, T. Arimoto, T. Yokoyama, et al. 2014. Oral vaccination against HPV E7 for treatment of cervical intraepithelial neoplasia grade 3 (CIN3) elicits E7-specific mucosal immunity in the cervix of CIN3 patients. Vaccine 32 (47):6233–6239. doi:10.1016/j.vaccine.2014.09.020.
   PubMed Web of Science ®Google Scholar
• Koné-Paut, I., S. Tellier, A. Belot, K. Brochard, C. Guitton, I. Marie, U. Meinzer, B. Cherqaoui, C. Galeotti, N. Boukhedouni, et al. 2020. Phase II open label study with anakinra in intravenous immunoglobulin-resistant Kawasaki disease. Arthritis Rheumatol. 73 (1):151–161. doi:10.1002/art.41481.
   PubMed Web of Science ®Google Scholar
• Lee, M. F., C. H. Chiang, Y. L. Li, N. M. Wang, P. P. Song, S. J. Lin, Y. H. Chen, and H.-C. Lai. 2018. Oral edible plant vaccine containing hypoallergen of American cockroach major allergen per a 2 prevents roach-allergic asthma in a murine model. PLoS One 13 (7):e0201281. doi:10.1371/journal.pone.0201281.
   PubMed Web of Science ®Google Scholar
• Lee, M. F., C. H. Chiang, S. J. Lin, P. P. Song, H. C. Liu, T. J. Wu, and W. W. Lin. 2020. Recombinant Lactococcus lactis expressing Ling Zhi 8 protein ameliorates nonalcoholic fatty liver and early atherogenesis in cholesterol-fed rabbits. BioMed. Res. Int. 2020:1–9. doi:10.1155/2020/3495682.
   Web of Science ®Google Scholar
• Lee, M. F., C. H. Chiang, S. J. Lin, C. S. Wu, Y. H. Chen, and M. L. S. Oliveira. 2021. Effectiveness and safety of oral lactococci-based vaccine encoding triple common allergens to prevent airway allergy in mice. PLoS One 16 (12):e026133. doi:10.1371/journal.pone.0261333.
   Web of Science ®Google Scholar
• Mierau, I., and M. Kleerebezem. 2005. 10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis. Appl. Microbiol. Biotechnol. 68 (6):705–717. doi:10.1007/s00253-005-0107-6.
   PubMed Web of Science ®Google Scholar
• Mierau, I., P. Leij, I. van Swam, B. Blommestein, E. Floris, J. Mond, and E. J. Smid. 2005. Industrial-scale production and purification of a heterologous protein in Lactococcus lactis using the nisin-controlled gene expression system NICE: The case of lysostaphin. Microb. Cell Fact. 4 (1):15. doi:10.1186/1475-2859-4-15.
   PubMedGoogle Scholar
• Nikfar, S., P. Saiyarsarai, B. M. Tigabu, and M. Abdollahi. 2018. Efficacy and safety of interleukin-1 antagonists in rheumatoid arthritis: A systematic review and meta-analysis. Rheumatol. Int. 38 (8):1363–1383. doi:10.1007/s00296-018-4041-1.
   PubMed Web of Science ®Google Scholar
• Powers, N. E., B. Swartzwelter, C. Marchetti, D. M. deGraaf, A. Lerchner, M. Schlapschy, R. Datar, U. Binder, C. K. Edwards, A. Skerra, et al. 2020. Pasylation of IL-1 receptor antagonist (IL-1Ra) retains IL-1 blockade and extends its duration in mouse urate crystal-induced peritonitis. J. Biol. Chem. 295 (3):868–882. doi:10.1016/S0021-9258(17)49941-8.
   PubMed Web of Science ®Google Scholar
• Ridker, P. M., B. M. Everett, T. Thuren, J. G. MacFadyen, W. H. Chang, C. Ballantyne, F. Fonseca, J. Nicolau, W. Koenig, S. D. Anker, et al. 2017. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377 (12):1119–1131. doi:10.1056/NEJMoa1707914.
   PubMed Web of Science ®Google Scholar
• Rosales-Mendoza, S., C. Angulo, and B. Meza. 2016. Food-grade organisms as vaccine biofactories and oral delivery vehicles. Trends Biotechnol. 34 (2):124–136. doi:10.1016/j.tibtech.2015.11.007.
   PubMed Web of Science ®Google Scholar
• Sheets, R., J. Stein, T. S. Manetz, C. Andrews, R. Bailer, J. Rathmann, and P. L. Gomez. 2006. Toxicological safety evaluation of DNA plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile virus is similar despite differing plasmid backbones or gene-inserts. Toxicol. Sci. 91 (2):620–630. doi:10.1093/toxsci/kfj170.
   PubMed Web of Science ®Google Scholar
• Shimizu, H., T. Mizuguchi, E. Tanaka, and S. Shioya. 1999. Nisin production by a mixed-culture system consisting of Lactococcus lactis and Kluyveromyces marxianus. Appl. Environ. Microb. 65 (7):3134–3141. doi:10.1128/AEM.65.7.3134-3141.1999.
   PubMed Web of Science ®Google Scholar
• Smelt, M. J., B. J. de Haan, P. A. Bron, I. van Swam, M. Meijerink, J. M. Wells, M. M. Faas, and P. de Vos. 2012. L. plantarum, L. salivarius, and L. lactis attenuate Th2 responses and increase Treg frequencies in healthy mice in a strain dependent manner. PLoS One 7 (10):e47244. doi:10.1371/journal.pone.0047244.
   PubMed Web of Science ®Google Scholar
• Valenta, R., R. Campana, M. Focke-Tejkl, and V. Niederberger. 2016. Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future. J. Allergy Clin. Immunol. 137 (2):351–357. doi:10.1016/j.jaci.2015.12.1299.
   PubMed Web of Science ®Google Scholar